Naturally occurring T-cell mutations power engineered T-cell therapies

Naturally occurring T-cell mutations power engineered T-cell therapies

  • Hou, AJ, Chen, LC & Chen, YY Navigation of CAR-T cells through the solid tumor microenvironment. Nat. Rev Drug Discov. 20531-550 (2021).

    Article CAS PubMed Google Scholar

  • Wang, L. et al. Genomic profiling of Sézary syndrome identifies alterations in key T cell signaling and differentiation genes. Nat. Genet. 471426-1434 (2015).

    CAS article PubMed PubMed Central Google Scholar

  • Rafiq, S., Hackett, C.S. & Brentjens, R.J. Engineering strategies to overcome current barriers in CAR T-cell therapy. Nat. Pastor Clean. Oncol. 17147-167 (2020).

    Article in PubMed Google Scholar

  • Larson, RC & Maus, MV Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21145-161 (2021).

    CAS article PubMed PubMed Central Google Scholar

  • Mustjoki, S. & Young, N.S. Somatic mutations in ‘benign’ disease. n. Engel. J Med. 3842039-2052 (2021).

    Article CAS PubMed Google Scholar

  • Walker, S. et al. Determine the gain function STAT3 Mutation (p.Y640F) in lymphocytic variant hypereosinophilia syndrome. blood 127948-951 (2016).

    Article PubMed PubMed Central Google Scholar

  • Park, J. et al. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function change in RLTPR (p.Q575E). blood 1301430-1440 (2017).

    CAS article PubMed PubMed Central Google Scholar

  • Park, J. et al. Integrated genomic analyzes of cutaneous T-cell lymphomas reveal the molecular bases of disease heterogeneity. blood 1381225-1236 (2021).

    CAS article PubMed PubMed Central Google Scholar

  • Daniels, J. et al. Cellular origins and genetic landscape of cutaneous gamma delta T-cell lymphomas. Nat. common. 111806-1806 (2020).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Statmour Edward, A. et al. CRISPR-engineered T cells in patients with resistant cancer. Sciences 367eaba7365 (2020).

    Article in PubMed Google Scholar

  • Fraietta, J. A. et al. Inactivation of TET2 enhances the therapeutic efficacy of CD19-targeted T cells. nature 558307-312 (2018).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Prinzing, B. et al. Deletion of DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity. Sci-fi. translation. Med. 13eabh0272.

  • Martinez, J. J. et al. The transcription factor NFAT promotes the exhaustion of activated CD8+ T cells. immunity 42265-278 (2015).

    CAS article PubMed PubMed Central Google Scholar

  • Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. nature 490116-120 (2012).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Liu, Y. et al. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Nat. Genet. 491211-1218 (2017).

    CAS article PubMed PubMed Central Google Scholar

  • Lin, R. C. et al. Overexpression of c-Jun in CAR T cells results in resistance to exhaustion. nature 576293-300 (2019).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Liggott, M. et al. A genome-wide screen for synthetic drivers of T cell proliferation. nature 603728-735 (2022).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Kahan, C. M. et al. Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate, stemness and protection decisions. Sci-fi. Immunol. 7eabl6322 (2022).

    CAS article PubMed PubMed Central Google Scholar

  • Ruland, J. & Hartjes, L. CARD-BCL-10-MALT1 signaling in protective and pathogenic immunity. Nat. Rev. Immunol. 19118-134 (2019).

    Article CAS PubMed Google Scholar

  • Jattani, RP, Tritapoe, JM & Pomerantz, JL Molecular interactions and cofactor regulation associated with the four repressive elements in caspase recruitment domain-containing protein 11 (CARD11). J Biol. Chemistry. 2918338-8348 (2016).

    CAS article PubMed PubMed Central Google Scholar

  • Burke, J. E. The structural basis for the regulation of phosphoinositide kinases and their involvement in human disease. mall. cell 71653-673 (2018).

    Article CAS PubMed Google Scholar

  • Kutzner, K. et al. Serine-893 phosphorylation of CARD11 inhibits the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells. Sci-fi. Signal. 15eabk3083.

  • Li, S., Yang, X., Shao, J. & Shen, Y. Structural insights into the assembly of CARMA1 and BCL10. One plus 7e42775 (2012).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Grossman, A. et al. Phosphotyrosine-dependent protein-protein interaction network. mall. the system. Biol. 11794 (2015).

    Article in PubMed Google Scholar

  • Fan, G Exp. Med. 211715-725 (2014).

    CAS article PubMed PubMed Central Google Scholar

  • Massarelli, E. et al. High OX-40 expression in tumor immune infiltrate is a favorable factor for overall survival in non-small cell lung cancer. J. Immunology. cancer 7351 (2019).

    Article PubMed PubMed Central Google Scholar

  • Bardet, M. et al. T-cell imprinting of MALT1 paracaspase was revealed by selective inhibition. Immunol. Cell Biol. 9681-99 (2018).

    Article CAS PubMed Google Scholar

  • Jiang, T., Zhou, C. & Ren, S. The role of IL-2 in cancer immunotherapy. Immuno-oncology 5e1163462 (2016).

    Article PubMed PubMed Central Google Scholar

  • Jedan, S. et al. Enhancing CAR T cell stability through ICOS and costimulation 4-1BB. JCI Insight https://doi.org/10.1172/jci.insight.96976 (2018).

  • King, MA et al. Non-infected human peripheral blood leukocytes in obesity, diabetes, and combined immunodeficiency Interleukin-2 receptor gamma chain A genetic mouse model of graft-versus-host disease and the role of the host major histocompatibility complex. Clean. Earn. Immunol. 157104-118 (2009).

    CAS article PubMed PubMed Central Google Scholar

  • Bidlingmaier, S. et al. Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelial and sarcomatoid types of mesothelioma. Cancer res. 691570-1577 (2009).

    CAS article PubMed PubMed Central Google Scholar

  • Li, Q.-X., Feuer, G., Ouyang, X. & An, X. Experimental animal modeling of immuno-oncology. Pharmacol. there. 17334-46 (2017).

    Article CAS PubMed Google Scholar

  • Kalbasi, A. et al. Enhancing adoptive cell therapy using synthetic IL-9 receptors. nature 607360-365 (2022).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Overwijk, WW & Restifo, NP B16 as a mouse model for human melanoma. the currency. Protoc. Immunol. https://doi.org/10.1002/0471142735.im2001s39 (2001).

  • Wei, J. et al. REGNASE-1 programs targeting long-lived effector T cells for cancer therapy. nature 576471-476 (2019).

    Article ADS CAS PubMed PubMed Central Google Scholar

  • Leidner, R. et al. Novel T-cell receptor gene therapy in pancreatic cancer. New English. J Med. 3862112-2119 (2022).

    Article CAS PubMed Google Scholar

  • Zhao, H. et al. Genome-wide identification of fitness genes reveals Roquin as a potent inhibitor of CD8 T cell expansion and anti-tumor immunity. Cell representative 37110083 (2021).

    Article CAS PubMed Google Scholar

  • The US Food and Drug Administration is investigating a serious risk of T-cell malignancies after BCMA-directed or CD19-directed T-cell immunotherapy. Food and Drug Administration https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous ( November 28, 2023).

  • Cappell, KM & Kochenderfer, JN Long-term outcomes after CAR T-cell therapy: what we know so far. Nat. Pastor Clean. Oncol. 20359-371 (2023).

    CAS article PubMed PubMed Central Google Scholar

  • Tward, J. D., Wendland, M. M., Shrieve, D. C., Szabo, A. & Gaffney, D. K. Risk of secondary malignancies over 30 years after treatment for non-Hodgkin lymphoma. cancer 107108-115 (2006).

    Article in PubMed Google Scholar

  • Chihara, D., Dores, G.M., Flowers, C.R. & Morton, L.M. Increased risk of B-cell lymphoma and bidirectional T-cell lymphoma. blood 138785-789 (2021).

    CAS article PubMed PubMed Central Google Scholar

  • Harrison, S. J. et al. car+ T-cell lymphoma after treatment with siltcaptagene for relapsed multiple myeloma. blood 1426939 (2023).

    Article Google Scholar

  • Pocock, S. J. et al. High incidence of treatment-related myelodysplasia and acute leukemia in general hematology clinic patients treated with fludarabine and cyclophosphamide for the treatment of indolent lymphoproliferative disorders. brother. J Hematol. 134242-243 (2006).

    Article in PubMed Google Scholar

  • Zhou, I. et al. Modular design of synthetic receptors for apoptotic gene regulation in cell therapies. cell 1851431-1443 (2022).

    CAS article PubMed PubMed Central Google Scholar

  • Marsot, L. et al. Engineering personalized cell sensing and response behaviors using synthetic Notch receptors. cell 164780-791 (2016).

    CAS article PubMed PubMed Central Google Scholar

  • Roybal, K. T. et al. Precise tumor recognition by T cells using combinatorial antigen sensing circuits. cell 164770-779 (2016).

    CAS article PubMed PubMed Central Google Scholar

  • Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphocytic leukemia. New English. J Med. 365725-733 (2011).

    Article CAS PubMed Google Scholar

  • Goetz, S. et al. Evaluation of costimulation and inhibition in a triple-tagged T cell reporter line: simultaneous measurement of NF-κB, NFAT and AP-1. J Immunol. Methods 43010-20 (2016).

    Article CAS PubMed Google Scholar

  • You may also like...

    Leave a Reply

    Your email address will not be published. Required fields are marked *